✦ LIBER ✦

Immune response to human papillomavirus after prophylactic vaccination with AS04-adjuvanted HPV-16/18 vaccine: Improving upon nature

✍ Scribed by Tino F. Schwarz; Oberdan Leo

Book ID: 113961656
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 806 KB
Volume: 110
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2008.05.036

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of the human papillomavirus (HP

Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15–25 years with and without serological evidence of previous exposure to HPV-16/18

✍ A. Szarewski; W.A.J. Poppe; S.R. Skinner; C.M. Wheeler; J. Paavonen; P. Naud; J. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 857 KB

Immunization of Early Adolescent Females

Immunization of Early Adolescent Females with Human Papillomavirus Type 16 and 18 L1 Virus-Like Particle Vaccine Containing AS04 Adjuvant

✍ Court Pedersen; Tiina Petaja; Gitte Strauss; Hans C. Rumke; Airi Poder; Jan Hend 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 583 KB

Long-term persistence of systemic and mu

Long-term persistence of systemic and mucosal immune response to HPV-16/18 AS04-adjuvanted vaccine in preteen/adolescent girls and young women

✍ Tiina Petäjä; Court Pedersen; Airi Poder; Gitte Strauss; Gregory Catteau; Floren 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 610 KB

## Abstract Vaccination against oncogenic human papillomavirus (HPV) types is one key intervention for cervical cancer prevention. This follow‐up study assessed the persistence of the systemic and mucosal immune responses together with the safety profile of the HPV‐16/18 AS04‐adjuvanted vaccine adm

Sustained efficacy and immunogenicity of

Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6·4 years

📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 248 KB

Immunogenicity and Safety of Human Papil

Immunogenicity and Safety of Human Papillomavirus-16/18 AS04-Adjuvanted Cervical Cancer Vaccine Coadministered With Combined Diphtheria-Tetanus-Acellular Pertussis–inactivated Poliovirus Vaccine to Girls and Young Women

✍ José Garcia-Sicilia; Tino F. Schwarz; Alfonso Carmona; Klaus Peters; Jean-Elie M 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 345 KB